PulseAugur
EN
LIVE 21:16:14
中文(ZH) 江山欧派：聘任陈春金为公司董事会秘书

Jiangshan Oupai Appoints New Board Secretary; Huiyu Pharma's Cancer Drug Trial Accepted

By PulseAugur Editorial · [1 sources] ·

Jiangshan Oupai has appointed Chen Chunjin as the company's board secretary, effective immediately. This move means the company's chairman, Wu Shuigen, will no longer perform the duties of the board secretary. Separately, Huiyu Pharmaceutical's subsidiary, Huiyu Haiyue, has received acceptance from the National Medical Products Administration for its clinical trial application for subcutaneous injection HY07121, a novel biological product designed to treat advanced solid tumors by targeting PD-1, TIGIT, and IL-15/IL-15Rα. AI

RANK_REASON The cluster contains two distinct, unrelated news items: a corporate personnel change and a clinical trial acceptance, neither of which meets the criteria for higher tiers.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Jiangshan Oupai Appoints New Board Secretary; Huiyu Pharma's Cancer Drug Trial Accepted

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The cluster contains two distinct, unrelated news items: a corporate personnel change and a clinical trial acceptance, neither of which meets the criteria for higher tiers.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
product, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
103 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Jiangshan Oupai: Appoints Chen Chunjin as Secretary of the Board of Directors

    36氪获悉，江山欧派公告，公司当天召开第五届董事会第二十三次会议，审议通过了《关于聘任公司董事会秘书的议案》，同意聘任陈春金为公司董事会秘书，任期自本次董事会审议通过之日起至第五届董事会任期届满之日止。公司董事长吴水根不再代行董事会秘书职责。

RELATED TOPICS